Liver transplants without blood type matching: a new hope?
NCT ID NCT07273448
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 100 people who received a liver transplant from a living donor with a different blood type. Researchers will track how long patients survive and how often their body rejects the new liver. The goal is to understand risks and improve care for these transplants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ABO-incompatible living donor liver transplantation
What this could lead to
If successful, this could help expand the donor pool for liver transplants, making more organs available to patients regardless of blood type.
What could go wrong
This is an observational study with only 100 participants, so results may not apply to all patients. There are known risks of rejection and complications after any transplant.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVING DONOR LIVER TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.